Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Beghini

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Heart Failure Reviews|September 23, 2024
Modulating energy metabolism to treat non-obstructive hypertrophic cardiomyopathy? Insights from IMPROVE-HCMAlberto Beghini, Alberto Aimo, Andrew P Ambrosy, et al.
ESC Heart Failure|May 28, 2024
2024 update in heart failureAlberto Beghini, Antonio Maria Sammartino, Zoltán Papp, et al.
JACC. Heart Failure|July 3, 2025
Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With TafamidisGiulio Sinigiani, Giuseppe Damiano Sanna, Alberto Aimo, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Heart Failure Reviews|September 23, 2024
Modulating energy metabolism to treat non-obstructive hypertrophic cardiomyopathy? Insights from IMPROVE-HCMAlberto Beghini, Alberto Aimo, Andrew P Ambrosy, et al.
ESC Heart Failure|May 28, 2024
2024 update in heart failureAlberto Beghini, Antonio Maria Sammartino, Zoltán Papp, et al.
JACC. Heart Failure|July 3, 2025
Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With TafamidisGiulio Sinigiani, Giuseppe Damiano Sanna, Alberto Aimo, et al.
Pageof 1